KAM
PFE icon

Krensavage Asset Management’s Pfizer PFE Stock Holding History

Krensavage Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,173
Closed -$419K – 25
2014
Q4 		$419K Buy
+14,173
New +$406K 0.23% 24

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Krensavage Asset Management's PFE Position: Q1 2015 in Review

Krensavage Asset Management sold out of Pfizer (PFE) in Q1 2015, closing a stake of 14,173 shares — an estimated $419K sold.

Krensavage Asset Management first reported a position in PFE in Q4 2014 and held it in 1 quarter. The position peaked at $419K in Q4 2014. 1,876 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Krensavage Asset Management reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
  • Krensavage Asset Management sold 14,173 Pfizer shares in Q1 2015, an estimated $419K.
  • Krensavage Asset Management first reported a position in Pfizer in Q4 2014 and held it in 1 quarter.
  • Krensavage Asset Management's Pfizer position peaked at $419K in Q4 2014.
  • 1,876 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Krensavage Asset Management's 13F filing for Q1 2015, filed 13 May 2015.